Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-centered Weifuchun treatment for chronic gastritis (real-world, prospective observational study)
ChiCTR2400079667Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of weifuchun in chronic gastritis, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Questionnaire evaluation of improvement of major clinical symptoms. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
weifuchun
03
Conditions
chronic gastritis
Beyond the preview
Go deeper on ChiCTR2400079667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079667.